On Sept. 19, the Food and Drug Administration (FDA) approved Exondys 51 (eteplirsen) injection, the first drug approved to treat patients with Duchenne muscular dystrophy (DMD). Read more
Reader Survey
Please share your feedback! We’re interested to learn more about your experience with American Nurse Journal.